
Biocell Technology Private Limited
About Biocell Technology Private Limited
Data last updated:
Biocell Technology Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2007.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2007PTC168517.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Vinod Singhania and Siddharth Singhania.
Its last annual general meeting (AGM) was held on 04 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 125 Atlanta 12th Floor Nariman Point, Mumbai, Maharashtra, India – 400021.
Company details
Contact details
Biocell Technology Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address125 Atlanta 12th Floor Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biocell Technology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biocell Technology is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Biocell Technology Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biocell Technology Private Limited, buy the company report.
Board of directors of Biocell Technology Private Limited
Biocell Technology has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Singhania Also directs: Unique Dreamscape LLP, Mountview Properties Limited Liability Partnership, Helion Mercantile LLP and 5 more | Director | 09 Mar 2007 | 19 Years 8 Months | As last reported |
| Siddharth Singhania | Director | 08 May 2008 | 18 Years 6 Months | As last reported |
Auditor
Biocell Technology Private Limited is audited by ABN & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABN & Co. | FY 2023 | 004447C |
Shareholding
The shareholding of Biocell Technology Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biocell Technology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biocell Technology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocell Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biocell Technology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biocell Technology Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Ravi Goenka Vasudeo ceased to be Director on 08 May 2008.
Frequently asked questions
Biocell Technology has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Biocell Technology was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2007 and is registered under CIN U24110MH2007PTC168517. The company has been struck off by the Registrar of Companies and is no longer operational.
Biocell Technology had 2 directors:
- Vinod Singhania - Director
- Siddharth Singhania - Director
The CIN (Corporate Identification Number) of Biocell Technology is U24110MH2007PTC168517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Biocell Technology is at 125 Atlanta 12th Floor Nariman Point, Mumbai, Maharashtra, India – 400021.
Biocell Technology was incorporated on 09 March 2007. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Biocell Technology on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 04 September 2023. Year-wise statements from 2015 are in the company report.
Biocell Technology operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Ravi Goenka Vasudeo ceased to be Director on 08 May 2008. Siddharth Singhania was appointed as Director on 08 May 2008. Vinod Singhania was appointed as Director on 09 Mar 2007.
The compliance status of Biocell Technology is compliant as of 02 August 2026.

